VN April 2026

Vetnuus | April 2026 15 is observed in approximately 90% of affected dogs [21]. Hence, tickborne fever infection may present as an acute febrile illness with low platelet counts [11, 22]. A. phagocytophilum evades host immune responses by impairing neutrophil function, which can predispose infected dogs to coinfection with other tick-borne pathogens, potentially complicating diagnosis and exacerbating clinical signs [23, 24]. Dogs are considered suitable hosts for ticks due to their behaviour and physical characteristics, and it has been suggested that dogs may even contribute to sustaining local tick populations, particularly in urban areas where alternative host animals are sparse [8]. Their exploration of nature increases their likelihood of exposure to questing ticks, and frequent movement through vegetation, such as tall grass and underbrush, places them at an ideal height for tick attachment. Additionally, their dense fur can make it difficult to spot attached ticks, providing sufficient time for pathogen transmission from the tick to the dog. Given their risk of tickborne infections and the following development of detectable antibody responses, dogs can serve as valuable sentinel animals [25, 26]. Because dogs often accompany their owners during outdoor activities, their tick exposure may also mirror that of humans, making them particularly useful for assessing human exposure risk [25, 26]. Hence, monitoring canine exposure may contribute important epidemiological data relevant to veterinary and public health. The present study aimed to estimate the seroprevalence of IgG antibodies against B. burgdorferi s. l., TBEV, and A. phagocytophilum in domestic dogs residing in Norway, and to assess their potential role as sentinel species for tickborne pathogen surveillance at the northernmost limit of I. ricinus’ geographical range. Methods Sample collection Blood samples from dogs were collected across 15 counties representing all five regions of Norway: Eastern, Southern, Western, Central, and Northern (Figure 1). Sampling was conducted from June 2016 to October 2023 using a non-systematic recruitment strategy. The study population comprised dogs of various ages, breeds, and both sexes, including neutered individuals. All dogs were already scheduled for veterinary consultations unrelated to tick-borne diseases during the study period, and additional blood samples were collected for research purposes, with oral consent from the dog owners. This was documented by the attending veterinarian in the medical record/journal. In addition, residual canine sera from clinical samples donated by dog owners were also obtained through the Central Laboratory at the Norwegian University of Life Sciences. In all cases, ethical approval for animal experiments was not required, as all dogs were already undergoing routine blood sampling as part of their veterinary visit. The blood samples were collected by veterinarians or veterinary nurses and allowed to clot at room temperature for 30 minutes before centrifugation at 2000 x g for 15 minutes. The serum was removed, aliquoted in microtubes, pseudonymized, stored at -20 ˚C, and transported to the University of Agder for further analyses. Detection of antibodies in dog sera by immunoblot Sera were analysed by the EUROLINE Tick-Borne Profile 1 Dog (IgG) kit (EUROIMMUN Medizinische Labordiagnostika AG, 23560 Lübeck, Germany), according to the manufacturer’s instructions. The immunoblot assay targets IgG-antibodies against B. burgdorferi s. l. (VIsE and OspC (p25)), TBEV (gpE), and A. phagocytophilum (MSP2). According to the manufacturer, due to the high quality of the antigen substrate, no cross-reactivity between B. burgdorferi s. l. and other species are expected. However, cross-reactions between A. phagocytophilum and Anaplasma platys, Ehrlichia spp., and Rickettsia spp. have been reported. Furthermore, cross-reactivity between TBEV and other flaviviruses cannot be excluded; however, the use of recombinant antigens significantly reduces the probability of such occurrences. According to the manufacturer, the sensitivity/ specificity of the test was as follows: 100%/100% for antibodies against B. burgdorferi s. l., 93%/91% for TBEV and 100%/91% for A. phagocytophilum. Results were automatically evaluated and classified as positive, negative, or borderline by the EUROLineScan program. Borderline results were interpreted as negative. Calculation of human Lyme borreliosis and tick-borne encephalitis incidence The number of registered cases of human Lyme borreliosis and tick-borne encephalitis (TBE) was obtained from the Norwegian Surveillance System for Communicable Diseases (MSIS) [14, 27]. The annual number of reported Lyme borreliosis cases in each region (county) was extracted for 2024, and incidence was calculated as the number of cases per 100,000 inhabitants per year. Population data for the corresponding year were retrieved from Statistics Norway [28]. Statistics Statistical analyses were performed with STATA/SE 17.0 (STATA Corp LLC., College Station, TX, USA, 2021). The Pearson Chi-square test was used to assess differences in seroprevalence across regions. Logistic regression analyses were conducted to assess whether observed regional differences in seroprevalence persisted after adjusting for potential confounders such as age, sex, and breed. Figure 1: Blood samples were collected from dogs across Norway. The number of included animals at each location is represented by dot size, while the different colours represent the five regions: Eastern (blue), Southern (yellow), Western (purple), Central (turquoise), and Northern Norway (green). >>>16 Article

RkJQdWJsaXNoZXIy OTc5MDU=